Davis, Janet L.

Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies

Schwartz, S. D., Regillo, C. D., Lam, B. L., Eliott, D., Rosenfeld, P. J., Gregori, N. Z., Hubschman, J.-P., Davis, J. L., Heilwell, G., Spirn, M., et al. (2015) · The Lancet

Retinal Development and DisordersRetinal Diseases and Treatments

Cited by 1,327

Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGR

Cehajic-Kapetanovic, J., Xue, K., Martinez-Fernandez de la Camara, C., Nanda, A., Davies, A., Wood, L. J., Salvetti, A. P., Fischer, M. D., Aylward, J. W., Barnard, A. R., et al. (2020) · Nature Medicine

Retinal Development and DisordersVirus-based gene therapy research

Cited by 368

Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis

Dick, A. D., Rosenbaum, J. T., Al-Dhibi, H. A., Belfort, R., Brézin, A. P., Chee, S. P., Davis, J. L., Ramanan, A. V., Sonoda, K.-H., Carreño, E., et al. (2018) · Ophthalmology

Ocular Diseases and Behçet’s SyndromeSpondyloarthritis Studies and Treatments

Cited by 285

Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis

Essman, T. F., Flynn, H. W., Smiddy, W. E., Brod, R. D., Murray, T. G., Davis, J. L., & Rubsamen, P. E. (1997) · Ophthalmic Surgery, Lasers and Imaging Retina

Ocular Infections and TreatmentsAntifungal resistance and susceptibility

Cited by 264

Gene Therapy for Leber Hereditary Optic Neuropathy

Feuer, W. J., Schiffman, J. C., Davis, J. L., Porciatti, V., Gonzalez, P., Koilkonda, R. D., Yuan, H., Lalwani, A., Lam, B. L., & Guy, J. (2016) · Ophthalmology

Virus-based gene therapy researchRetinal Development and Disorders

Cited by 230

Gene Therapy for Leber Hereditary Optic Neuropathy

Guy, J., Feuer, W. J., Davis, J. L., Porciatti, V., Gonzalez, P. J., Koilkonda, R. D., Yuan, H., Hauswirth, W. W., & Lam, B. L. (2017) · Ophthalmology

Virus-based gene therapy researchRetinal Development and Disorders

Cited by 204

Choroideremia gene therapy phase 2 clinical trial: 24-month results

Lam, B. L., Davis, J. L., Gregori, N. Z., MacLaren, R. E., Girach, A., Verriotto, J. D., Rodriguez, B., Rosa, P. R., Zhang, X., & Feuer, W. J. (2019) · American Journal of Ophthalmology

Retinal Development and DisordersRetinal Diseases and Treatments

Cited by 161

Surgical technique for subretinal gene therapy in humans with inherited retinal degeneration

Davis, J. L., Gregori, N. Z., MacLaren, R. E., & Lam, B. L. (2019) · Retina

Retinal Development and DisordersRetinal Diseases and Treatments

Cited by 72

Intraoperative use of microscope-integrated optical coherence tomography for subretinal gene therapy delivery

Gregori, N. Z., Lam, B. L., & Davis, J. L. (2019) · Retina

Retinal Development and DisordersRetinal Diseases and Treatments

Cited by 54

Assessment of visual function with cotoretigene toliparvovec in X-linked retinitis pigmentosa in the randomized XIRIUS phase 2/3 study

Lam, B. L., Pennesi, M. E., Kay, C. N., Panda, S., Gow, J. A., Zhao, G., MacLaren, R. E., MacLaren, R., Aleman, T., Birch, D., et al. (2024) · Ophthalmology

Retinal Development and DisordersVirus-based gene therapy research

Cited by 51

Leber hereditary optic neuropathy gene therapy: adverse events and visual acuity results of all patient groups

Lam, B. L., Feuer, W. J., Davis, J. L., Porciatti, V., Yu, H., Levy, R. B., Vanner, E., & Guy, J. (2022) · American Journal of Ophthalmology

Virus-based gene therapy researchRetinal Development and Disorders

Cited by 43